StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.90+0.02 (+0.18%)

Close on Nov 17, 2026Market cap $2.38BP/E –Yield –

Neogen r&d expenses

Research and development expenses are spending on new products and technology.

Neogen's R&D Expenses for the twelve months ending Aug 31, 2026 was $19.76M, down 5.9% year over year. For fiscal 2026 it was $18.40M, down 12.8% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $26.04M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026May 31, 2026$18.40M-12.8%
FY2025May 31, 2025$21.10M-6.2%
FY2024May 31, 2024$22.50M-13.6%
FY2023May 31, 2023$26.04M+52.7%
FY2022May 31, 2022$17.05M+4.9%
FY2021May 31, 2021$16.25M+10.1%
FY2020May 31, 2020$14.75M+15.2%
FY2019May 31, 2019$12.81M+18.0%
FY2018May 31, 2018$10.86M+4.5%
FY2017May 31, 2017$10.39M+5.0%
FY2016May 31, 2016$9.89M+3.3%
FY2015May 31, 2015$9.58M+15.0%
FY2014May 31, 2014$8.33M+7.0%
FY2013May 31, 2013$7.78M+17.3%
FY2012May 31, 2012$6.64M-2.8%
FY2011May 31, 2011$6.83M+9.1%
FY2010May 31, 2010$6.26M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$6.50M+27.5%
Q4 FY2026CQ2 2026May 31, 2026$4.90M-22.2%
Q3 FY2026CQ1 2026Feb 28, 2026$3.80M-15.6%
Q2 FY2026CQ4 2025Nov 30, 2025$4.56M-10.7%
Q1 FY2026CQ3 2025Aug 31, 2025$5.10M-1.9%
Q4 FY2025CQ2 2025May 31, 2025$6.30M+21.9%
Q3 FY2025CQ1 2025Feb 28, 2025$4.50M-7.3%
Q2 FY2025CQ4 2024Nov 30, 2024$5.11M-11.3%
Q1 FY2025CQ3 2024Aug 31, 2024$5.20M-22.7%
Q4 FY2024CQ2 2024May 31, 2024$5.17M-26.7%
Q3 FY2024CQ1 2024Feb 29, 2024$4.85M-33.1%
Q2 FY2024CQ4 2023Nov 30, 2023$5.76M-15.9%
Q1 FY2024CQ3 2023Aug 31, 2023$6.72M+37.7%
Q4 FY2023CQ2 2023May 31, 2023$7.05M+84.1%
Q3 FY2023CQ1 2023Feb 28, 2023$7.26M+59.1%
Q2 FY2023CQ4 2022Nov 30, 2022$6.85M+58.0%
Q1 FY2023CQ3 2022Aug 31, 2022$4.88M+12.9%
Q4 FY2022CQ2 2022May 31, 2022$3.83M-6.0%
Q3 FY2022CQ1 2022Feb 28, 2022$4.56M+7.7%
Q2 FY2022CQ4 2021Nov 30, 2021$4.33M+6.8%
Q1 FY2022CQ3 2021Aug 31, 2021$4.33M+11.5%
Q4 FY2021CQ2 2021May 31, 2021$4.08M+17.9%
Q3 FY2021CQ1 2021Feb 28, 2021$4.24M+10.8%
Q2 FY2021CQ4 2020Nov 30, 2020$4.06M+7.3%
Q1 FY2021CQ3 2020Aug 31, 2020$3.88M+5.2%
Q4 FY2020CQ2 2020May 31, 2020$3.46M-3.1%
Q3 FY2020CQ1 2020Feb 29, 2020$3.82M+17.7%
Q2 FY2020CQ4 2019Nov 30, 2019$3.78M+19.4%
Q1 FY2020CQ3 2019Aug 31, 2019$3.69M+30.8%
Q4 FY2019CQ2 2019May 31, 2019$3.57M+82.7%
Q3 FY2019CQ1 2019Feb 28, 2019$3.25M+14.6%
Q2 FY2019CQ4 2018Nov 30, 2018$3.17M+6.7%
Q1 FY2019CQ3 2018Aug 31, 2018$2.82M-9.0%
Q4 FY2018CQ2 2018May 31, 2018$1.95M-15.0%
Q3 FY2018CQ1 2018Feb 28, 2018$2.84M+7.4%
Q2 FY2018CQ4 2017Nov 30, 2017$2.97M+7.2%
Q1 FY2018CQ3 2017Aug 31, 2017$3.10M–
Q4 FY2017CQ2 2017May 31, 2017$2.30M–
Q3 FY2017CQ1 2017Feb 28, 2017$2.64M–
Q2 FY2017CQ4 2016Nov 30, 2016$2.77M–

More Neogen figures

See a number that looks wrong?